**Core Concept**
Intermediate uveitis is a form of **uveitis** that affects the intermediate zone of the eye, which includes the **vitreous** and **peripheral retina**. The underlying principle being tested is the management of this condition, which often involves the use of **corticosteroids** or other **immunosuppressive agents**.

**Why the Correct Answer is Right**
Since the correct answer isn't specified, let's discuss a common approach to treating intermediate uveitis. **Corticosteroids**, particularly **prednisone**, are often considered first-line treatment due to their potent anti-inflammatory effects. They can be administered orally or via periocular injections.

**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, a common incorrect choice might be an **NSAID**, which, while useful for mild inflammation, is not sufficient for the treatment of intermediate uveitis.
**Option B:** Another incorrect option could be an **antibiotic**, which would be inappropriate unless there's a confirmed infectious cause.
**Option C:** If this option were a **biologic agent**, it might be considered for refractory cases but not typically as the first line.
**Option D:** If this were a **different class of steroid**, the reasoning might depend on the specific drug and its common uses.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that the treatment of intermediate uveitis aims to reduce inflammation and prevent complications such as **cystoid macular edema**.

**Correct Answer:** Correct Answer: D. Prednisone.